4.4 Review

Relatively slow and long-lasting antimigraine effect of dihydroergotamine is most likely due to basic pharmacological attributes of the drug: A review

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Sumatriptan: a review of its pharmacokinetics, pharmacodynamics and efficacy in the acute treatment of migraine

Peer Tfelt-Hansen et al.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)

Editorial Material Pharmacology & Pharmacy

MAP0004: dihydroergotamine mesylate inhalation aerosol for acute treatment of migraine

Stephen Silberstein

EXPERT OPINION ON PHARMACOTHERAPY (2012)

Article Clinical Neurology

Acute Treatment of Migraine: Established and Emerging Therapies

Alan M. Rapoport

HEADACHE (2012)

Review Pharmacology & Pharmacy

Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action

Georges Vauquelin et al.

BRITISH JOURNAL OF PHARMACOLOGY (2010)

Review Clinical Neurology

Current practice and future directions in the prevention and acute management of migraine

Peter J. Goadsby et al.

LANCET NEUROLOGY (2010)

Article Clinical Neurology

DHE in the pharmacotherapy of migraine: Potential for a larger role

Joel R. Saper et al.

HEADACHE (2006)

Article Pharmacology & Pharmacy

Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data

JNJM de Hoon et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)

Letter Clinical Neurology

A comment on time-to-event analysis for headache relief

P Tfelt-Hansen

CEPHALALGIA (2000)